AI assistant
EXELIXIS, INC. — Director's Dealing 2023
Jan 27, 2023
30561_dirs_2023-01-26_3b23b83f-8109-45d6-8348-a3ced43dc288.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2023-01-24
Reporting Person: MORRISSEY MICHAEL (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-07 | Common Stock | G | 106010 | — | Disposed | 340655 | Direct |
| 2022-12-07 | Common Stock | G | 106010 | — | Acquired | 1302326 | Indirect |
| 2023-01-24 | Common Stock | M | 100000 | $4.20 | Acquired | 440655 | Direct |
| 2023-01-24 | Common Stock | F | 62006 | $17.36 | Disposed | 378649 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-01-24 | Option (right to buy) | $4.2 | M | 100000 | Disposed | 2023-02-10 | Common Stock (100000.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 17728 | Indirect |
Footnotes
F1: On December 7, 2022, the Reporting Person gifted 106,010 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended.
F2: Includes 340,655 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F3: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
F4: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 37,994 shares of Common Stock on the net exercise of a stock option to purchase 100,000 shares of Common Stock. The Issuer withheld 62,006 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on January 24, 2023 of $17.36.
F5: Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of January 24, 2023.
F6: The option, representing the right to purchase a total of 150,000 shares of Common Stock, became fully exercisable on February 11, 2020.